ArticleCancer gene therapy2004

Decreased tumorigenic potential of EphA2-overexpressing breast cancer cells following treatment with adenoviral vectors that express EphrinA1.

Loren W Noblitt et al.PubMed ↗Publisher ↗

No numbers read from the abstract.